Orlando, FL -- (SBWIRE) -- 10/28/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Zogenix, Inc.(NASDAQ:ZGNX), BioTime, Inc.(NYSEMKT:BTX).
Zogenix, Inc.(NASDAQ:ZGNX): Stifel notes, on Friday, the FDA approved painkiller Zohydro ER following a lengthy delay amidst intense regulatory scrutiny of the opioid class. Due to risks of opioid addiction, abuse, misuse and overdose/death, Zohydro is reserved for patients intolerant to or inadequately treated by alternative options for pain. As expected, labeling will include updated ER/LA warnings announced by FDA.
Notably, Zohydro will enter the market with a level playing field after FDA's move yesterday to reclassify all hydrocodone combination products as Schedule II substances from Schedule III. Given ZGNX's clear financing needs ($16mn 2Q13 cash, ~$10-15mn quarterly burn), firm expects serious negotiations regarding acquisition/partnership.
Are investors worried about the recent updates with ZGNX? Find out with a free trend analysis HERE
Asterias Biotherapeutics, a majority-owned subsidiary of BioTime, Inc.(NYSEMKT:BTX), announced that it plans to file a registration statement with the Securities and Exchange Commission in November 2013 for an underwritten public offering of units, with each unit consisting of one share of Series B common stock, $0.0001 par value per share, and one redemption right in respect of one share of Series B common stock. The shares of Series B common stock and redemption rights will immediately separate after purchase and will be freely tradable as separate securities after the closing of the offering.
Asterias plans to use the net proceeds of the offering, expected to be between $12 million and $15 million, to fund its product development programs and for working capital. Asterias plans to apply to list the Series B common stock on the NYSE MKT under the symbol AST. Prices for the redemption rights are expected to be quoted on the OTC Bulletin Board. The number of units to be offered and the price range for the units have not yet been determined.
Is BTX going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)